Parallelized Droplet Vitrification for Single-Run Vitrification of Hepatocytes from an Entire Rat Liver
Drug discovery pipelines rely on the availability of isolated primary hepatocytes for investigating potential hepatotoxicity prior to clinical application. These hepatocytes are isolated from livers rejected for transplantation and subsequently cryopreserved for later usage. The gold standard cryopreservation technique, slow-freezing, is a labor-intensive process with significant poststorage viability loss. In this work, we introduce parallelized droplet vitrification, a technique for high-volumetric, rapid vitrification of suspended cells. We show the utility of this technique through the single-run vitrification of the whole rat liver hepatocyte yield, resulting in the vitrification of 250 million cells in 40 mL of a vitrification solution at 10 mL/min. Additionally, we showed that these implementations maintained improved postpreservation outcomes in primary rat hepatocytes.
Authors
- Korkut Uygun
- Alexandre G. Lellouch (ORCID: https://orcid.org/0000-0001-8191-8662)
- Mehmet Toner (ORCID: https://orcid.org/0000-0002-3647-3665)
- Rebecca D. Sandlin (ORCID: https://orcid.org/0000-0003-3077-2135)
- McLean S. Taggart (ORCID: https://orcid.org/0000-0003-3889-3513)
- Loïc Van Dieren (ORCID: https://orcid.org/0000-0003-0781-4691)
- Antonia T. Dinicu
- Alexandra Tchir
- Huyun Chen (ORCID: https://orcid.org/0009-0006-9248-8550)
- Christopher Taveras
- Madeeha Hassan
Institutions
- Harvard University (US)
- Inserm (FR)
- Massachusetts General Hospital (US)
- Shriners Hospitals for Children - Boston (US)
- Laboratoire d'Innovation Thérapeutique (FR)
- Center For Reconstructive Urethral Surgery (IT)
- Innovations Thérapeutiques en Hémostase (FR)
- Massachusetts Institute of Technology (US)
Publication Details
- Journal
- ACS Applied Materials & Interfaces
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1021/acsami.4c19419
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Biomedical Imaging and Bioengineering
- Division of Engineering Education and Centers